Kenneth K. Sokoll
Plus aucun poste en cours
Profil
Dr. Kenneth K.
Sokoll is Chief Operating Officer & VP-Clinical Development at PharmaGap, Inc.
Dr. Sokoll was previously employed as Vice President-Vaccine Product Development by United Biomedical, Inc., Gérant by Aventis Pasteur Sa, Gérant by Rhodia SA, Vice President-Drug Development by Liponex, Inc., and Vice President-Drug Development by Milestone Pharmaceuticals, Inc.
He received his undergraduate degree from the University of Toronto and a doctorate degree from The University of Waterloo.
Anciens postes connus de Kenneth K. Sokoll
| Sociétés | Poste | Fin |
|---|---|---|
United Biomedical, Inc.
 United Biomedical, Inc. Pharmaceuticals: MajorHealth Technology United Biomedical, Inc. manufactures biological vaccines and other immunizing products. It engages in discovery, development and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases. The firm’s vaccines are used for the treatment and prevention of alzheimer’s disease, AIDS, and allergy, along with a portfolio of animal health diseases. The company was founded by Nean Hu and Chang Yi Wang in 1985 and is headquartered in Hauppauge, NY. | Corporate Officer/Principal | - |
Solvay France SA
 Solvay France SA Chemicals: Major DiversifiedProcess Industries Solvay France SA engages in the production of specialty chemicals. The company was founded in 1863 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
| Aventis Pasteur Sa | Corporate Officer/Principal | - |
PharmaGap, Inc.
 PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | Directeur des opérations | - |
| Liponex, Inc. | Corporate Officer/Principal | - |
Formation de Kenneth K. Sokoll
| University of Toronto | Undergraduate Degree |
| The University of Waterloo | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Solvay France SA
Solvay France SA Chemicals: Major DiversifiedProcess Industries Solvay France SA engages in the production of specialty chemicals. The company was founded in 1863 and is headquartered in Paris, France. | Process Industries |
PharmaGap, Inc.
PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | Health Technology |
| Liponex, Inc. | Health Technology |
| Aventis Pasteur Sa | Health Technology |
United Biomedical, Inc.
United Biomedical, Inc. Pharmaceuticals: MajorHealth Technology United Biomedical, Inc. manufactures biological vaccines and other immunizing products. It engages in discovery, development and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases. The firm’s vaccines are used for the treatment and prevention of alzheimer’s disease, AIDS, and allergy, along with a portfolio of animal health diseases. The company was founded by Nean Hu and Chang Yi Wang in 1985 and is headquartered in Hauppauge, NY. | Health Technology |
